nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—CYP2D6—Carteolol—glaucoma	0.0419	0.14	CbGbCtD
Pazopanib—CYP1A2—Betaxolol—glaucoma	0.0344	0.114	CbGbCtD
Pazopanib—CYP2D6—Betaxolol—glaucoma	0.0283	0.0943	CbGbCtD
Pazopanib—CYP2D6—Methazolamide—glaucoma	0.0215	0.0715	CbGbCtD
Pazopanib—CYP3A4—Pilocarpine—glaucoma	0.0202	0.0673	CbGbCtD
Pazopanib—FGF1—corneal epithelium—glaucoma	0.0199	0.176	CbGeAlD
Pazopanib—ABCB1—Timolol—glaucoma	0.0194	0.0645	CbGbCtD
Pazopanib—CYP1A2—Clonidine—glaucoma	0.0188	0.0627	CbGbCtD
Pazopanib—CYP2D6—Timolol—glaucoma	0.0183	0.0608	CbGbCtD
Pazopanib—ABCB1—Clonidine—glaucoma	0.0165	0.0548	CbGbCtD
Pazopanib—CYP3A4—Brinzolamide—glaucoma	0.0159	0.0528	CbGbCtD
Pazopanib—CYP2D6—Clonidine—glaucoma	0.0155	0.0517	CbGbCtD
Pazopanib—CYP3A4—Dorzolamide—glaucoma	0.0153	0.051	CbGbCtD
Pazopanib—FGF1—cornea—glaucoma	0.0145	0.128	CbGeAlD
Pazopanib—FGFR2—cornea—glaucoma	0.0137	0.121	CbGeAlD
Pazopanib—CYP3A4—Methazolamide—glaucoma	0.0136	0.0454	CbGbCtD
Pazopanib—CYP3A4—Acetazolamide—glaucoma	0.0109	0.0363	CbGbCtD
Pazopanib—CYP3A4—Clonidine—glaucoma	0.00987	0.0329	CbGbCtD
Pazopanib—FLT4—endothelium—glaucoma	0.00409	0.0361	CbGeAlD
Pazopanib—FGF1—endothelium—glaucoma	0.00363	0.0321	CbGeAlD
Pazopanib—TAOK1—eye—glaucoma	0.00326	0.0288	CbGeAlD
Pazopanib—FLT1—endothelium—glaucoma	0.00318	0.0281	CbGeAlD
Pazopanib—SH2B3—eye—glaucoma	0.00307	0.0271	CbGeAlD
Pazopanib—SH2B3—retina—glaucoma	0.00304	0.0269	CbGeAlD
Pazopanib—KDR—endothelium—glaucoma	0.00269	0.0238	CbGeAlD
Pazopanib—LYN—connective tissue—glaucoma	0.00249	0.022	CbGeAlD
Pazopanib—FGFR3—connective tissue—glaucoma	0.00248	0.0219	CbGeAlD
Pazopanib—KIT—endothelium—glaucoma	0.00238	0.021	CbGeAlD
Pazopanib—FLT4—eye—glaucoma	0.00201	0.0177	CbGeAlD
Pazopanib—PIP4K2C—retina—glaucoma	0.00198	0.0175	CbGeAlD
Pazopanib—MAP3K2—connective tissue—glaucoma	0.00182	0.0161	CbGeAlD
Pazopanib—FGF1—eye—glaucoma	0.00178	0.0158	CbGeAlD
Pazopanib—FGF1—retina—glaucoma	0.00177	0.0156	CbGeAlD
Pazopanib—FGF1—connective tissue—glaucoma	0.00172	0.0152	CbGeAlD
Pazopanib—FGFR2—eye—glaucoma	0.00168	0.0149	CbGeAlD
Pazopanib—FGFR2—connective tissue—glaucoma	0.00162	0.0143	CbGeAlD
Pazopanib—FLT1—eye—glaucoma	0.00156	0.0138	CbGeAlD
Pazopanib—FLT1—retina—glaucoma	0.00155	0.0137	CbGeAlD
Pazopanib—FLT1—connective tissue—glaucoma	0.0015	0.0133	CbGeAlD
Pazopanib—TAOK3—eye—glaucoma	0.00147	0.013	CbGeAlD
Pazopanib—TAOK3—retina—glaucoma	0.00146	0.0129	CbGeAlD
Pazopanib—TAOK3—connective tissue—glaucoma	0.00142	0.0125	CbGeAlD
Pazopanib—PDGFRA—connective tissue—glaucoma	0.00141	0.0124	CbGeAlD
Pazopanib—KDR—eye—glaucoma	0.00132	0.0117	CbGeAlD
Pazopanib—KDR—retina—glaucoma	0.00131	0.0116	CbGeAlD
Pazopanib—CSF1R—eye—glaucoma	0.00129	0.0114	CbGeAlD
Pazopanib—KDR—connective tissue—glaucoma	0.00127	0.0112	CbGeAlD
Pazopanib—CSF1R—connective tissue—glaucoma	0.00124	0.011	CbGeAlD
Pazopanib—PDGFRB—eye—glaucoma	0.00114	0.0101	CbGeAlD
Pazopanib—KIT—connective tissue—glaucoma	0.00113	0.00995	CbGeAlD
Pazopanib—PDGFRB—connective tissue—glaucoma	0.0011	0.00972	CbGeAlD
Pazopanib—ABCB1—retina—glaucoma	0.000314	0.00277	CbGeAlD
Pazopanib—Shock—Pilocarpine—glaucoma	0.000257	0.000768	CcSEcCtD
Pazopanib—Thrombocytopenia—Pilocarpine—glaucoma	0.000255	0.000765	CcSEcCtD
Pazopanib—Erythema—Clonidine—glaucoma	0.000255	0.000764	CcSEcCtD
Pazopanib—Dyspepsia—Brimonidine—glaucoma	0.000254	0.000762	CcSEcCtD
Pazopanib—Hypoaesthesia—Betaxolol—glaucoma	0.000254	0.00076	CcSEcCtD
Pazopanib—Hyperhidrosis—Pilocarpine—glaucoma	0.000252	0.000755	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000251	0.000753	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Travoprost—glaucoma	0.00025	0.00075	CcSEcCtD
Pazopanib—Insomnia—Dorzolamide—glaucoma	0.00025	0.000748	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Brimonidine—glaucoma	0.000249	0.000747	CcSEcCtD
Pazopanib—Fatigue—Brimonidine—glaucoma	0.000249	0.000746	CcSEcCtD
Pazopanib—Anorexia—Pilocarpine—glaucoma	0.000249	0.000744	CcSEcCtD
Pazopanib—Paraesthesia—Dorzolamide—glaucoma	0.000248	0.000742	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000247	0.00074	CcSEcCtD
Pazopanib—Pain—Brimonidine—glaucoma	0.000247	0.00074	CcSEcCtD
Pazopanib—Dyspnoea—Dorzolamide—glaucoma	0.000246	0.000737	CcSEcCtD
Pazopanib—Insomnia—Brinzolamide—glaucoma	0.000245	0.000735	CcSEcCtD
Pazopanib—Somnolence—Dorzolamide—glaucoma	0.000245	0.000735	CcSEcCtD
Pazopanib—Muscle spasms—Clonidine—glaucoma	0.000245	0.000735	CcSEcCtD
Pazopanib—Dyspnoea—Travoprost—glaucoma	0.000245	0.000734	CcSEcCtD
Pazopanib—Paraesthesia—Brinzolamide—glaucoma	0.000244	0.00073	CcSEcCtD
Pazopanib—Dyspepsia—Dorzolamide—glaucoma	0.000243	0.000728	CcSEcCtD
Pazopanib—Dyspnoea—Brinzolamide—glaucoma	0.000242	0.000724	CcSEcCtD
Pazopanib—Dyspepsia—Travoprost—glaucoma	0.000242	0.000724	CcSEcCtD
Pazopanib—Asthenia—Apraclonidine—glaucoma	0.000242	0.000723	CcSEcCtD
Pazopanib—Somnolence—Brinzolamide—glaucoma	0.000241	0.000722	CcSEcCtD
Pazopanib—Vision blurred—Clonidine—glaucoma	0.00024	0.00072	CcSEcCtD
Pazopanib—Decreased appetite—Dorzolamide—glaucoma	0.00024	0.000719	CcSEcCtD
Pazopanib—Dyspepsia—Brinzolamide—glaucoma	0.000239	0.000715	CcSEcCtD
Pazopanib—Eye disorder—Betaxolol—glaucoma	0.000238	0.000714	CcSEcCtD
Pazopanib—Pruritus—Apraclonidine—glaucoma	0.000238	0.000713	CcSEcCtD
Pazopanib—Fatigue—Dorzolamide—glaucoma	0.000238	0.000713	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000238	0.000712	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Travoprost—glaucoma	0.000237	0.000711	CcSEcCtD
Pazopanib—Fatigue—Travoprost—glaucoma	0.000237	0.00071	CcSEcCtD
Pazopanib—Flushing—Betaxolol—glaucoma	0.000237	0.000709	CcSEcCtD
Pazopanib—Cardiac disorder—Betaxolol—glaucoma	0.000237	0.000709	CcSEcCtD
Pazopanib—Pain—Dorzolamide—glaucoma	0.000236	0.000707	CcSEcCtD
Pazopanib—Insomnia—Pilocarpine—glaucoma	0.000236	0.000706	CcSEcCtD
Pazopanib—Decreased appetite—Brinzolamide—glaucoma	0.000236	0.000706	CcSEcCtD
Pazopanib—Weight decreased—Timolol—glaucoma	0.000236	0.000706	CcSEcCtD
Pazopanib—Pain—Travoprost—glaucoma	0.000235	0.000704	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000234	0.000702	CcSEcCtD
Pazopanib—Paraesthesia—Pilocarpine—glaucoma	0.000234	0.000701	CcSEcCtD
Pazopanib—Asthenia—Bimatoprost—glaucoma	0.000234	0.000701	CcSEcCtD
Pazopanib—Fatigue—Brinzolamide—glaucoma	0.000234	0.000701	CcSEcCtD
Pazopanib—Dyspnoea—Pilocarpine—glaucoma	0.000232	0.000696	CcSEcCtD
Pazopanib—Pain—Brinzolamide—glaucoma	0.000232	0.000695	CcSEcCtD
Pazopanib—Somnolence—Pilocarpine—glaucoma	0.000232	0.000694	CcSEcCtD
Pazopanib—Angiopathy—Betaxolol—glaucoma	0.000232	0.000693	CcSEcCtD
Pazopanib—Pruritus—Bimatoprost—glaucoma	0.000231	0.000692	CcSEcCtD
Pazopanib—Diarrhoea—Apraclonidine—glaucoma	0.00023	0.00069	CcSEcCtD
Pazopanib—Mediastinal disorder—Betaxolol—glaucoma	0.00023	0.000689	CcSEcCtD
Pazopanib—Dyspepsia—Pilocarpine—glaucoma	0.00023	0.000688	CcSEcCtD
Pazopanib—Chills—Betaxolol—glaucoma	0.000229	0.000686	CcSEcCtD
Pazopanib—Syncope—Clonidine—glaucoma	0.000229	0.000685	CcSEcCtD
Pazopanib—Decreased appetite—Pilocarpine—glaucoma	0.000227	0.000679	CcSEcCtD
Pazopanib—Gastrointestinal pain—Dorzolamide—glaucoma	0.000226	0.000676	CcSEcCtD
Pazopanib—Alopecia—Betaxolol—glaucoma	0.000226	0.000675	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000225	0.000674	CcSEcCtD
Pazopanib—Gastrointestinal pain—Travoprost—glaucoma	0.000225	0.000673	CcSEcCtD
Pazopanib—Loss of consciousness—Clonidine—glaucoma	0.000224	0.000672	CcSEcCtD
Pazopanib—Mental disorder—Betaxolol—glaucoma	0.000224	0.00067	CcSEcCtD
Pazopanib—Pain—Pilocarpine—glaucoma	0.000223	0.000668	CcSEcCtD
Pazopanib—Cough—Clonidine—glaucoma	0.000223	0.000667	CcSEcCtD
Pazopanib—Dizziness—Apraclonidine—glaucoma	0.000223	0.000667	CcSEcCtD
Pazopanib—Erythema—Betaxolol—glaucoma	0.000222	0.000665	CcSEcCtD
Pazopanib—Malnutrition—Betaxolol—glaucoma	0.000222	0.000665	CcSEcCtD
Pazopanib—Epistaxis—Timolol—glaucoma	0.000219	0.000656	CcSEcCtD
Pazopanib—Abdominal pain—Dorzolamide—glaucoma	0.000218	0.000653	CcSEcCtD
Pazopanib—Dysgeusia—Betaxolol—glaucoma	0.000218	0.000652	CcSEcCtD
Pazopanib—Chest pain—Clonidine—glaucoma	0.000217	0.000651	CcSEcCtD
Pazopanib—Arthralgia—Clonidine—glaucoma	0.000217	0.000651	CcSEcCtD
Pazopanib—Abdominal pain—Travoprost—glaucoma	0.000217	0.000651	CcSEcCtD
Pazopanib—Asthenia—Acetazolamide—glaucoma	0.000216	0.000647	CcSEcCtD
Pazopanib—Dizziness—Bimatoprost—glaucoma	0.000216	0.000646	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000216	0.000646	CcSEcCtD
Pazopanib—Vomiting—Apraclonidine—glaucoma	0.000214	0.000641	CcSEcCtD
Pazopanib—Muscle spasms—Betaxolol—glaucoma	0.000214	0.00064	CcSEcCtD
Pazopanib—Gastrointestinal pain—Pilocarpine—glaucoma	0.000213	0.000639	CcSEcCtD
Pazopanib—Dry mouth—Clonidine—glaucoma	0.000212	0.000636	CcSEcCtD
Pazopanib—Bradycardia—Timolol—glaucoma	0.000212	0.000636	CcSEcCtD
Pazopanib—Dermatitis—Apraclonidine—glaucoma	0.000212	0.000635	CcSEcCtD
Pazopanib—Headache—Apraclonidine—glaucoma	0.000211	0.000632	CcSEcCtD
Pazopanib—Vision blurred—Betaxolol—glaucoma	0.000209	0.000627	CcSEcCtD
Pazopanib—Oedema—Clonidine—glaucoma	0.000208	0.000624	CcSEcCtD
Pazopanib—Asthenia—Brimonidine—glaucoma	0.000207	0.000621	CcSEcCtD
Pazopanib—Infection—Clonidine—glaucoma	0.000207	0.00062	CcSEcCtD
Pazopanib—Abdominal pain—Pilocarpine—glaucoma	0.000206	0.000617	CcSEcCtD
Pazopanib—Diarrhoea—Acetazolamide—glaucoma	0.000206	0.000617	CcSEcCtD
Pazopanib—Rash—Bimatoprost—glaucoma	0.000206	0.000616	CcSEcCtD
Pazopanib—Dermatitis—Bimatoprost—glaucoma	0.000206	0.000616	CcSEcCtD
Pazopanib—Oedema peripheral—Timolol—glaucoma	0.000205	0.000615	CcSEcCtD
Pazopanib—Anaemia—Betaxolol—glaucoma	0.000205	0.000615	CcSEcCtD
Pazopanib—Shock—Clonidine—glaucoma	0.000205	0.000614	CcSEcCtD
Pazopanib—Connective tissue disorder—Timolol—glaucoma	0.000205	0.000614	CcSEcCtD
Pazopanib—Pruritus—Brimonidine—glaucoma	0.000204	0.000612	CcSEcCtD
Pazopanib—Headache—Bimatoprost—glaucoma	0.000204	0.000612	CcSEcCtD
Pazopanib—Nervous system disorder—Clonidine—glaucoma	0.000204	0.000612	CcSEcCtD
Pazopanib—Thrombocytopenia—Clonidine—glaucoma	0.000204	0.000611	CcSEcCtD
Pazopanib—Skin disorder—Clonidine—glaucoma	0.000202	0.000606	CcSEcCtD
Pazopanib—Hyperhidrosis—Clonidine—glaucoma	0.000201	0.000603	CcSEcCtD
Pazopanib—Nausea—Apraclonidine—glaucoma	0.0002	0.000599	CcSEcCtD
Pazopanib—Syncope—Betaxolol—glaucoma	0.000199	0.000597	CcSEcCtD
Pazopanib—Dizziness—Acetazolamide—glaucoma	0.000199	0.000596	CcSEcCtD
Pazopanib—Anorexia—Clonidine—glaucoma	0.000199	0.000595	CcSEcCtD
Pazopanib—Asthenia—Dorzolamide—glaucoma	0.000198	0.000593	CcSEcCtD
Pazopanib—Asthenia—Travoprost—glaucoma	0.000197	0.00059	CcSEcCtD
Pazopanib—Pruritus—Dorzolamide—glaucoma	0.000195	0.000585	CcSEcCtD
Pazopanib—Loss of consciousness—Betaxolol—glaucoma	0.000195	0.000585	CcSEcCtD
Pazopanib—Eye disorder—Timolol—glaucoma	0.000195	0.000584	CcSEcCtD
Pazopanib—Asthenia—Brinzolamide—glaucoma	0.000195	0.000583	CcSEcCtD
Pazopanib—Pruritus—Travoprost—glaucoma	0.000194	0.000582	CcSEcCtD
Pazopanib—Cough—Betaxolol—glaucoma	0.000194	0.000581	CcSEcCtD
Pazopanib—Nausea—Bimatoprost—glaucoma	0.000194	0.000581	CcSEcCtD
Pazopanib—Cardiac disorder—Timolol—glaucoma	0.000193	0.000579	CcSEcCtD
Pazopanib—Pruritus—Brinzolamide—glaucoma	0.000192	0.000575	CcSEcCtD
Pazopanib—Vomiting—Acetazolamide—glaucoma	0.000191	0.000573	CcSEcCtD
Pazopanib—Dizziness—Brimonidine—glaucoma	0.000191	0.000572	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Clonidine—glaucoma	0.00019	0.000568	CcSEcCtD
Pazopanib—Angiopathy—Timolol—glaucoma	0.000189	0.000567	CcSEcCtD
Pazopanib—Myalgia—Betaxolol—glaucoma	0.000189	0.000566	CcSEcCtD
Pazopanib—Chest pain—Betaxolol—glaucoma	0.000189	0.000566	CcSEcCtD
Pazopanib—Arthralgia—Betaxolol—glaucoma	0.000189	0.000566	CcSEcCtD
Pazopanib—Diarrhoea—Dorzolamide—glaucoma	0.000189	0.000566	CcSEcCtD
Pazopanib—Headache—Acetazolamide—glaucoma	0.000189	0.000565	CcSEcCtD
Pazopanib—Insomnia—Clonidine—glaucoma	0.000188	0.000564	CcSEcCtD
Pazopanib—Diarrhoea—Travoprost—glaucoma	0.000188	0.000563	CcSEcCtD
Pazopanib—Mediastinal disorder—Timolol—glaucoma	0.000188	0.000563	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000188	0.000563	CcSEcCtD
Pazopanib—Asthenia—Pilocarpine—glaucoma	0.000187	0.00056	CcSEcCtD
Pazopanib—Paraesthesia—Clonidine—glaucoma	0.000187	0.00056	CcSEcCtD
Pazopanib—Dyspnoea—Clonidine—glaucoma	0.000186	0.000556	CcSEcCtD
Pazopanib—Diarrhoea—Brinzolamide—glaucoma	0.000186	0.000556	CcSEcCtD
Pazopanib—Somnolence—Clonidine—glaucoma	0.000185	0.000554	CcSEcCtD
Pazopanib—Dry mouth—Betaxolol—glaucoma	0.000185	0.000554	CcSEcCtD
Pazopanib—Pruritus—Pilocarpine—glaucoma	0.000185	0.000553	CcSEcCtD
Pazopanib—Alopecia—Timolol—glaucoma	0.000184	0.000552	CcSEcCtD
Pazopanib—Mental disorder—Timolol—glaucoma	0.000183	0.000547	CcSEcCtD
Pazopanib—Dizziness—Dorzolamide—glaucoma	0.000183	0.000547	CcSEcCtD
Pazopanib—Rash—Brimonidine—glaucoma	0.000182	0.000546	CcSEcCtD
Pazopanib—Dermatitis—Brimonidine—glaucoma	0.000182	0.000545	CcSEcCtD
Pazopanib—Dizziness—Travoprost—glaucoma	0.000182	0.000544	CcSEcCtD
Pazopanib—Erythema—Timolol—glaucoma	0.000181	0.000544	CcSEcCtD
Pazopanib—Malnutrition—Timolol—glaucoma	0.000181	0.000544	CcSEcCtD
Pazopanib—Oedema—Betaxolol—glaucoma	0.000181	0.000543	CcSEcCtD
Pazopanib—Headache—Brimonidine—glaucoma	0.000181	0.000542	CcSEcCtD
Pazopanib—Decreased appetite—Clonidine—glaucoma	0.000181	0.000542	CcSEcCtD
Pazopanib—Infection—Betaxolol—glaucoma	0.00018	0.000539	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Clonidine—glaucoma	0.00018	0.000538	CcSEcCtD
Pazopanib—Fatigue—Clonidine—glaucoma	0.00018	0.000538	CcSEcCtD
Pazopanib—Dizziness—Brinzolamide—glaucoma	0.000179	0.000537	CcSEcCtD
Pazopanib—Nausea—Acetazolamide—glaucoma	0.000179	0.000536	CcSEcCtD
Pazopanib—Diarrhoea—Pilocarpine—glaucoma	0.000178	0.000534	CcSEcCtD
Pazopanib—Shock—Betaxolol—glaucoma	0.000178	0.000534	CcSEcCtD
Pazopanib—Pain—Clonidine—glaucoma	0.000178	0.000533	CcSEcCtD
Pazopanib—Nervous system disorder—Betaxolol—glaucoma	0.000178	0.000533	CcSEcCtD
Pazopanib—Dysgeusia—Timolol—glaucoma	0.000178	0.000532	CcSEcCtD
Pazopanib—Thrombocytopenia—Betaxolol—glaucoma	0.000178	0.000532	CcSEcCtD
Pazopanib—Skin disorder—Betaxolol—glaucoma	0.000176	0.000527	CcSEcCtD
Pazopanib—Vomiting—Dorzolamide—glaucoma	0.000175	0.000526	CcSEcCtD
Pazopanib—Hyperhidrosis—Betaxolol—glaucoma	0.000175	0.000525	CcSEcCtD
Pazopanib—Rash—Dorzolamide—glaucoma	0.000174	0.000521	CcSEcCtD
Pazopanib—Dermatitis—Dorzolamide—glaucoma	0.000174	0.000521	CcSEcCtD
Pazopanib—Rash—Travoprost—glaucoma	0.000173	0.000519	CcSEcCtD
Pazopanib—Dermatitis—Travoprost—glaucoma	0.000173	0.000518	CcSEcCtD
Pazopanib—Headache—Dorzolamide—glaucoma	0.000173	0.000518	CcSEcCtD
Pazopanib—Anorexia—Betaxolol—glaucoma	0.000173	0.000518	CcSEcCtD
Pazopanib—Vomiting—Brinzolamide—glaucoma	0.000173	0.000517	CcSEcCtD
Pazopanib—Dizziness—Pilocarpine—glaucoma	0.000172	0.000516	CcSEcCtD
Pazopanib—Headache—Travoprost—glaucoma	0.000172	0.000516	CcSEcCtD
Pazopanib—Nausea—Brimonidine—glaucoma	0.000172	0.000514	CcSEcCtD
Pazopanib—Rash—Brinzolamide—glaucoma	0.000171	0.000512	CcSEcCtD
Pazopanib—Vision blurred—Timolol—glaucoma	0.000171	0.000512	CcSEcCtD
Pazopanib—Dermatitis—Brinzolamide—glaucoma	0.000171	0.000512	CcSEcCtD
Pazopanib—Gastrointestinal pain—Clonidine—glaucoma	0.00017	0.00051	CcSEcCtD
Pazopanib—Headache—Brinzolamide—glaucoma	0.00017	0.000509	CcSEcCtD
Pazopanib—Vomiting—Pilocarpine—glaucoma	0.000166	0.000497	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000165	0.000495	CcSEcCtD
Pazopanib—Abdominal pain—Clonidine—glaucoma	0.000165	0.000493	CcSEcCtD
Pazopanib—Rash—Pilocarpine—glaucoma	0.000164	0.000492	CcSEcCtD
Pazopanib—Dermatitis—Pilocarpine—glaucoma	0.000164	0.000492	CcSEcCtD
Pazopanib—Insomnia—Betaxolol—glaucoma	0.000164	0.000491	CcSEcCtD
Pazopanib—Nausea—Dorzolamide—glaucoma	0.000164	0.000491	CcSEcCtD
Pazopanib—Headache—Pilocarpine—glaucoma	0.000163	0.000489	CcSEcCtD
Pazopanib—Nausea—Travoprost—glaucoma	0.000163	0.000489	CcSEcCtD
Pazopanib—Paraesthesia—Betaxolol—glaucoma	0.000163	0.000488	CcSEcCtD
Pazopanib—Syncope—Timolol—glaucoma	0.000163	0.000487	CcSEcCtD
Pazopanib—Dyspnoea—Betaxolol—glaucoma	0.000162	0.000484	CcSEcCtD
Pazopanib—Nausea—Brinzolamide—glaucoma	0.000161	0.000483	CcSEcCtD
Pazopanib—Dyspepsia—Betaxolol—glaucoma	0.00016	0.000478	CcSEcCtD
Pazopanib—Loss of consciousness—Timolol—glaucoma	0.00016	0.000478	CcSEcCtD
Pazopanib—Cough—Timolol—glaucoma	0.000158	0.000474	CcSEcCtD
Pazopanib—Decreased appetite—Betaxolol—glaucoma	0.000158	0.000472	CcSEcCtD
Pazopanib—Hypertension—Timolol—glaucoma	0.000157	0.000469	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Betaxolol—glaucoma	0.000157	0.000469	CcSEcCtD
Pazopanib—Fatigue—Betaxolol—glaucoma	0.000156	0.000468	CcSEcCtD
Pazopanib—Pain—Betaxolol—glaucoma	0.000155	0.000464	CcSEcCtD
Pazopanib—Nausea—Pilocarpine—glaucoma	0.000155	0.000464	CcSEcCtD
Pazopanib—Arthralgia—Timolol—glaucoma	0.000155	0.000463	CcSEcCtD
Pazopanib—Chest pain—Timolol—glaucoma	0.000155	0.000463	CcSEcCtD
Pazopanib—Myalgia—Timolol—glaucoma	0.000155	0.000463	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000153	0.00046	CcSEcCtD
Pazopanib—Dry mouth—Timolol—glaucoma	0.000151	0.000453	CcSEcCtD
Pazopanib—Asthenia—Clonidine—glaucoma	0.000149	0.000448	CcSEcCtD
Pazopanib—Oedema—Timolol—glaucoma	0.000148	0.000444	CcSEcCtD
Pazopanib—Pruritus—Clonidine—glaucoma	0.000147	0.000441	CcSEcCtD
Pazopanib—Infection—Timolol—glaucoma	0.000147	0.000441	CcSEcCtD
Pazopanib—Shock—Timolol—glaucoma	0.000146	0.000436	CcSEcCtD
Pazopanib—Nervous system disorder—Timolol—glaucoma	0.000145	0.000435	CcSEcCtD
Pazopanib—Skin disorder—Timolol—glaucoma	0.000144	0.000431	CcSEcCtD
Pazopanib—Hyperhidrosis—Timolol—glaucoma	0.000143	0.000429	CcSEcCtD
Pazopanib—Diarrhoea—Clonidine—glaucoma	0.000142	0.000427	CcSEcCtD
Pazopanib—Anorexia—Timolol—glaucoma	0.000141	0.000423	CcSEcCtD
Pazopanib—Dizziness—Clonidine—glaucoma	0.000138	0.000412	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Timolol—glaucoma	0.000135	0.000404	CcSEcCtD
Pazopanib—Insomnia—Timolol—glaucoma	0.000134	0.000401	CcSEcCtD
Pazopanib—Paraesthesia—Timolol—glaucoma	0.000133	0.000398	CcSEcCtD
Pazopanib—Vomiting—Clonidine—glaucoma	0.000132	0.000397	CcSEcCtD
Pazopanib—Dyspnoea—Timolol—glaucoma	0.000132	0.000395	CcSEcCtD
Pazopanib—Somnolence—Timolol—glaucoma	0.000132	0.000394	CcSEcCtD
Pazopanib—Rash—Clonidine—glaucoma	0.000131	0.000393	CcSEcCtD
Pazopanib—Dermatitis—Clonidine—glaucoma	0.000131	0.000393	CcSEcCtD
Pazopanib—Headache—Clonidine—glaucoma	0.00013	0.000391	CcSEcCtD
Pazopanib—Dyspepsia—Timolol—glaucoma	0.00013	0.00039	CcSEcCtD
Pazopanib—Asthenia—Betaxolol—glaucoma	0.00013	0.00039	CcSEcCtD
Pazopanib—Decreased appetite—Timolol—glaucoma	0.000129	0.000386	CcSEcCtD
Pazopanib—Pruritus—Betaxolol—glaucoma	0.000128	0.000384	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Timolol—glaucoma	0.000128	0.000383	CcSEcCtD
Pazopanib—Fatigue—Timolol—glaucoma	0.000128	0.000382	CcSEcCtD
Pazopanib—Pain—Timolol—glaucoma	0.000127	0.000379	CcSEcCtD
Pazopanib—Diarrhoea—Betaxolol—glaucoma	0.000124	0.000372	CcSEcCtD
Pazopanib—Nausea—Clonidine—glaucoma	0.000124	0.00037	CcSEcCtD
Pazopanib—Gastrointestinal pain—Timolol—glaucoma	0.000121	0.000363	CcSEcCtD
Pazopanib—Dizziness—Betaxolol—glaucoma	0.00012	0.000359	CcSEcCtD
Pazopanib—Abdominal pain—Timolol—glaucoma	0.000117	0.000351	CcSEcCtD
Pazopanib—Vomiting—Betaxolol—glaucoma	0.000115	0.000345	CcSEcCtD
Pazopanib—Rash—Betaxolol—glaucoma	0.000114	0.000342	CcSEcCtD
Pazopanib—Dermatitis—Betaxolol—glaucoma	0.000114	0.000342	CcSEcCtD
Pazopanib—Headache—Betaxolol—glaucoma	0.000114	0.00034	CcSEcCtD
Pazopanib—Nausea—Betaxolol—glaucoma	0.000108	0.000323	CcSEcCtD
Pazopanib—Asthenia—Timolol—glaucoma	0.000106	0.000318	CcSEcCtD
Pazopanib—Pruritus—Timolol—glaucoma	0.000105	0.000314	CcSEcCtD
Pazopanib—Diarrhoea—Timolol—glaucoma	0.000101	0.000304	CcSEcCtD
Pazopanib—Dizziness—Timolol—glaucoma	9.79e-05	0.000293	CcSEcCtD
Pazopanib—Vomiting—Timolol—glaucoma	9.42e-05	0.000282	CcSEcCtD
Pazopanib—Rash—Timolol—glaucoma	9.34e-05	0.00028	CcSEcCtD
Pazopanib—Dermatitis—Timolol—glaucoma	9.33e-05	0.000279	CcSEcCtD
Pazopanib—Headache—Timolol—glaucoma	9.28e-05	0.000278	CcSEcCtD
Pazopanib—Nausea—Timolol—glaucoma	8.8e-05	0.000263	CcSEcCtD
Pazopanib—FGF1—Signaling Pathways—CAV1—glaucoma	1.22e-05	4.81e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—APOE—glaucoma	1.21e-05	4.81e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—FN1—glaucoma	1.21e-05	4.8e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CDKN2B—glaucoma	1.21e-05	4.8e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CDKN2B—glaucoma	1.21e-05	4.79e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—TXN—glaucoma	1.21e-05	4.78e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CAV1—glaucoma	1.2e-05	4.76e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CYP1B1—glaucoma	1.2e-05	4.76e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ABCA1—glaucoma	1.2e-05	4.76e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—PTGS2—glaucoma	1.2e-05	4.75e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—BAD—glaucoma	1.2e-05	4.75e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—BAD—glaucoma	1.2e-05	4.74e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CA2—glaucoma	1.19e-05	4.72e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NTRK1—glaucoma	1.18e-05	4.68e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—CDKN1B—glaucoma	1.18e-05	4.66e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.17e-05	4.61e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.17e-05	4.61e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NTRK2—glaucoma	1.16e-05	4.61e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—EDN1—glaucoma	1.16e-05	4.61e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—MMP9—glaucoma	1.16e-05	4.6e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—EDN1—glaucoma	1.16e-05	4.59e-05	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—TNF—glaucoma	1.16e-05	4.58e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NTRK1—glaucoma	1.16e-05	4.58e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—FN1—glaucoma	1.16e-05	4.58e-05	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—TP53—glaucoma	1.16e-05	4.57e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NGF—glaucoma	1.15e-05	4.54e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—BAD—glaucoma	1.14e-05	4.53e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—CDKN1B—glaucoma	1.14e-05	4.5e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—C3—glaucoma	1.13e-05	4.49e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—GSTM1—glaucoma	1.13e-05	4.48e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—BAD—glaucoma	1.13e-05	4.48e-05	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CDKN1B—glaucoma	1.13e-05	4.47e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NGF—glaucoma	1.13e-05	4.46e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—NOS3—glaucoma	1.11e-05	4.38e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.1e-05	4.36e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.09e-05	4.32e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—C3—glaucoma	1.09e-05	4.32e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CDKN2B—glaucoma	1.09e-05	4.31e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—VEGFA—glaucoma	1.09e-05	4.3e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—NOS3—glaucoma	1.09e-05	4.3e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—BCL2L1—glaucoma	1.09e-05	4.3e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—C3—glaucoma	1.07e-05	4.24e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NGF—glaucoma	1.07e-05	4.23e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CDKN2B—glaucoma	1.07e-05	4.22e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—NOS3—glaucoma	1.07e-05	4.22e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NGF—glaucoma	1.07e-05	4.22e-05	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.06e-05	4.21e-05	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—TP53—glaucoma	1.06e-05	4.18e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—TXN—glaucoma	1.05e-05	4.16e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—MTHFR—glaucoma	1.05e-05	4.14e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—EDN1—glaucoma	1.05e-05	4.14e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—VEGFA—glaucoma	1.04e-05	4.13e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—GSTM1—glaucoma	1.04e-05	4.11e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—EDN1—glaucoma	1.02e-05	4.05e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CDKN1B—glaucoma	1.02e-05	4.03e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—C3—glaucoma	1.02e-05	4.02e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—APOE—glaucoma	1.02e-05	4.02e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—C3—glaucoma	1.01e-05	4.01e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—NOS3—glaucoma	1.01e-05	4.01e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—NOS3—glaucoma	1.01e-05	4e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CAV1—glaucoma	1.01e-05	3.98e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CA1—glaucoma	1.01e-05	3.98e-05	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—TP53—glaucoma	1e-05	3.96e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—CDKN1B—glaucoma	1e-05	3.96e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—MTHFR—glaucoma	1e-05	3.96e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NGFR—glaucoma	9.99e-06	3.95e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—APOE—glaucoma	9.97e-06	3.95e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—PTGS2—glaucoma	9.94e-06	3.93e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—TXN—glaucoma	9.91e-06	3.92e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—NOS3—glaucoma	9.89e-06	3.91e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CAV1—glaucoma	9.88e-06	3.91e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—BAD—glaucoma	9.84e-06	3.89e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—PTGS2—glaucoma	9.76e-06	3.86e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—APOE—glaucoma	9.75e-06	3.86e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CTSA—glaucoma	9.74e-06	3.86e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CAV1—glaucoma	9.66e-06	3.82e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—NOS3—glaucoma	9.64e-06	3.81e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GSTM1—glaucoma	9.61e-06	3.8e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NGF—glaucoma	9.61e-06	3.8e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—CDKN1B—glaucoma	9.58e-06	3.79e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—FN1—glaucoma	9.58e-06	3.79e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CDKN1B—glaucoma	9.5e-06	3.76e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NTRK1—glaucoma	9.49e-06	3.76e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CDKN1B—glaucoma	9.48e-06	3.75e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—APOE—glaucoma	9.46e-06	3.75e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—BAD—glaucoma	9.46e-06	3.75e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—APOE—glaucoma	9.44e-06	3.74e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—CDKN1B—glaucoma	9.41e-06	3.72e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NGF—glaucoma	9.41e-06	3.72e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—FN1—glaucoma	9.4e-06	3.72e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CAV1—glaucoma	9.38e-06	3.71e-05	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	9.37e-06	3.71e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GSTT1—glaucoma	9.36e-06	3.71e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CAV1—glaucoma	9.35e-06	3.7e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—APOE—glaucoma	9.32e-06	3.69e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—BAD—glaucoma	9.29e-06	3.68e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—PTGS2—glaucoma	9.26e-06	3.67e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—CDKN1B—glaucoma	9.24e-06	3.66e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—PTGS2—glaucoma	9.24e-06	3.66e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—CAV1—glaucoma	9.23e-06	3.65e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CA2—glaucoma	9.2e-06	3.64e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—NOS3—glaucoma	9.19e-06	3.64e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—MTHFR—glaucoma	9.17e-06	3.63e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—C3—glaucoma	9.14e-06	3.62e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—NOS3—glaucoma	9.1e-06	3.6e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—BAD—glaucoma	9.08e-06	3.59e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—C3—glaucoma	8.94e-06	3.54e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—FN1—glaucoma	8.93e-06	3.53e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—FN1—glaucoma	8.9e-06	3.52e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—MMP9—glaucoma	8.87e-06	3.51e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—BAD—glaucoma	8.82e-06	3.49e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—BAD—glaucoma	8.8e-06	3.48e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CDKN1B—glaucoma	8.77e-06	3.47e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CDKN1B—glaucoma	8.75e-06	3.46e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CDKN2B—glaucoma	8.75e-06	3.46e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CDKN1B—glaucoma	8.56e-06	3.39e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—APOE—glaucoma	8.54e-06	3.38e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CDKN1B—glaucoma	8.54e-06	3.38e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—APOE—glaucoma	8.5e-06	3.37e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—MTHFR—glaucoma	8.49e-06	3.36e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—CAV1—glaucoma	8.46e-06	3.35e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CAV1—glaucoma	8.43e-06	3.34e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TXN—glaucoma	8.4e-06	3.32e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EDN1—glaucoma	8.39e-06	3.32e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—CDKN1B—glaucoma	8.36e-06	3.31e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CDKN1B—glaucoma	8.35e-06	3.3e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—APOE—glaucoma	8.33e-06	3.3e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PTGS2—glaucoma	8.32e-06	3.29e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CAV1—glaucoma	8.25e-06	3.27e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—TP53—glaucoma	8.21e-06	3.25e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GSTT1—glaucoma	8.16e-06	3.23e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—FN1—glaucoma	8.02e-06	3.17e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—VEGFA—glaucoma	7.97e-06	3.15e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CDKN1B—glaucoma	7.96e-06	3.15e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—MMP9—glaucoma	7.93e-06	3.14e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—BAD—glaucoma	7.92e-06	3.14e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—APOE—glaucoma	7.91e-06	3.13e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TP53—glaucoma	7.88e-06	3.12e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CDKN1B—glaucoma	7.88e-06	3.12e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—FN1—glaucoma	7.85e-06	3.11e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CAV1—glaucoma	7.83e-06	3.1e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—BAD—glaucoma	7.76e-06	3.07e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—MMP9—glaucoma	7.73e-06	3.06e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NGF—glaucoma	7.71e-06	3.05e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GSTT1—glaucoma	7.69e-06	3.04e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.66e-06	3.03e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NOS3—glaucoma	7.61e-06	3.01e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.59e-06	3.01e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.55e-06	2.99e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NOS3—glaucoma	7.47e-06	2.96e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ABCA1—glaucoma	7.46e-06	2.95e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CYP1B1—glaucoma	7.46e-06	2.95e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—MMP9—glaucoma	7.37e-06	2.92e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—C3—glaucoma	7.33e-06	2.9e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—NOS3—glaucoma	7.3e-06	2.89e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—VEGFA—glaucoma	7.12e-06	2.82e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NOS3—glaucoma	7.09e-06	2.81e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NOS3—glaucoma	7.07e-06	2.8e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—NOS3—glaucoma	6.98e-06	2.76e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—VEGFA—glaucoma	6.94e-06	2.75e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CDKN1B—glaucoma	6.85e-06	2.71e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—APOE—glaucoma	6.82e-06	2.7e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CAV1—glaucoma	6.76e-06	2.68e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—PTGS2—glaucoma	6.68e-06	2.64e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—VEGFA—glaucoma	6.62e-06	2.62e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CDKN1B—glaucoma	6.59e-06	2.61e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GSTT1—glaucoma	6.51e-06	2.58e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ABCA1—glaucoma	6.5e-06	2.57e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CYP1B1—glaucoma	6.5e-06	2.57e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TXN—glaucoma	6.48e-06	2.57e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CDKN1B—glaucoma	6.47e-06	2.56e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—FN1—glaucoma	6.44e-06	2.55e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—NOS3—glaucoma	6.4e-06	2.53e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTGS2—glaucoma	6.39e-06	2.53e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NOS3—glaucoma	6.37e-06	2.52e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—BAD—glaucoma	6.36e-06	2.52e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CDKN1B—glaucoma	6.32e-06	2.5e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NOS3—glaucoma	6.24e-06	2.47e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CDKN1B—glaucoma	6.14e-06	2.43e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CDKN1B—glaucoma	6.13e-06	2.42e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CYP1B1—glaucoma	6.12e-06	2.42e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ABCA1—glaucoma	6.12e-06	2.42e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MMP9—glaucoma	6.1e-06	2.42e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TP53—glaucoma	6.02e-06	2.38e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MMP9—glaucoma	5.99e-06	2.37e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GSTM1—glaucoma	5.96e-06	2.36e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—NOS3—glaucoma	5.92e-06	2.34e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTGS2—glaucoma	5.85e-06	2.32e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MMP9—glaucoma	5.69e-06	2.25e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MMP9—glaucoma	5.67e-06	2.25e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CDKN1B—glaucoma	5.52e-06	2.18e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—VEGFA—glaucoma	5.48e-06	2.17e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTGS2—glaucoma	5.42e-06	2.14e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CDKN1B—glaucoma	5.4e-06	2.14e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—VEGFA—glaucoma	5.38e-06	2.13e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—glaucoma	5.38e-06	2.13e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MTHFR—glaucoma	5.27e-06	2.09e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.25e-06	2.08e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—glaucoma	5.25e-06	2.08e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GSTM1—glaucoma	5.2e-06	2.06e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ABCA1—glaucoma	5.19e-06	2.05e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CYP1B1—glaucoma	5.19e-06	2.05e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NOS3—glaucoma	5.11e-06	2.02e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MMP9—glaucoma	5.11e-06	2.02e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—VEGFA—glaucoma	5.11e-06	2.02e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—VEGFA—glaucoma	5.1e-06	2.02e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTT1—glaucoma	5.03e-06	1.99e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MMP9—glaucoma	5e-06	1.98e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—glaucoma	5e-06	1.98e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—APOE—glaucoma	4.91e-06	1.94e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GSTM1—glaucoma	4.9e-06	1.94e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CAV1—glaucoma	4.86e-06	1.92e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MTHFR—glaucoma	4.59e-06	1.82e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—VEGFA—glaucoma	4.59e-06	1.82e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—VEGFA—glaucoma	4.49e-06	1.78e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CDKN1B—glaucoma	4.43e-06	1.75e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MTHFR—glaucoma	4.33e-06	1.71e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—APOE—glaucoma	4.27e-06	1.69e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CAV1—glaucoma	4.24e-06	1.68e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GSTM1—glaucoma	4.15e-06	1.64e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—glaucoma	4.14e-06	1.64e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MMP9—glaucoma	4.1e-06	1.62e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—glaucoma	4.07e-06	1.61e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—APOE—glaucoma	4.03e-06	1.59e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ABCA1—glaucoma	4e-06	1.59e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP1B1—glaucoma	4e-06	1.59e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CAV1—glaucoma	3.99e-06	1.58e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—glaucoma	3.86e-06	1.53e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—glaucoma	3.85e-06	1.52e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—VEGFA—glaucoma	3.68e-06	1.46e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—NOS3—glaucoma	3.68e-06	1.46e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MTHFR—glaucoma	3.67e-06	1.45e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—glaucoma	3.47e-06	1.37e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—APOE—glaucoma	3.41e-06	1.35e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—glaucoma	3.4e-06	1.34e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CAV1—glaucoma	3.38e-06	1.34e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTGS2—glaucoma	3.36e-06	1.33e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NOS3—glaucoma	3.2e-06	1.27e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTM1—glaucoma	3.2e-06	1.27e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NOS3—glaucoma	3.02e-06	1.19e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTGS2—glaucoma	2.93e-06	1.16e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MTHFR—glaucoma	2.83e-06	1.12e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—glaucoma	2.78e-06	1.1e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS2—glaucoma	2.76e-06	1.09e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOE—glaucoma	2.63e-06	1.04e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CAV1—glaucoma	2.61e-06	1.03e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NOS3—glaucoma	2.56e-06	1.01e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS2—glaucoma	2.34e-06	9.26e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NOS3—glaucoma	1.97e-06	7.81e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS2—glaucoma	1.8e-06	7.14e-06	CbGpPWpGaD
